Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ Prophylactic anticonvulsant therapy prior to neurosurgery is controversialPatients should continue their preoperative anticonvulsants as long as they have therapeutic drug levelsPhenytoin 100 mg Q8 hours or levetiracetam 500 mg are the most common regimensLevetiracetam is now being used more often due to broad-spectrum seizure coverage and lower side effects, and serum therapeutic levels do not need to be checked ++Table Graphic Jump Location|Download (.pdf)|PrintCommon Preoperative Anticonvulsant Regimens and Side EffectsDrugDoseSide effectsCarbamazepine (Tegretol®)400 mg po tidBlurred vision, ataxia, sedation, hyponatremia, rashEthosuximide (Zarontin®)500 mg po q dayNausea, vomiting, ataxia, GI distress, drowsinessGabapentin (Neurontin®)300–1200 mg po tidDrowsiness, weight gain, peripheral edemaLamotrigine (Lamictal®)200 mg po bidRash, Stevens–Johnson’s, red cell aplasia, DIC, hepatic or renal failureLevetiracetam (Keppra®)1000 mg po bidIrritability, somnolenceOxcarbazepine (Trileptal®)600 mg po bidHyponatremia, rash, interactions with oral contraceptivesPhenobarbital (Solfoton®)100 mg po q dayDrowsiness, confusion, slurred speech, ataxia, hypotension, respiratory depression, nystagmusPhenytoin (Dilantin®)300–400 mg po q dayVertigo, somnolence, ataxia, gingival hyperplasia, hirsutismTopiramate (Topamax®)150–200 mg po bidCNS side effects, nephrolithiasis, open-angle glaucoma, weight lossValproate (Depakene®)250–500 mg po tidGI disturbance, sedation, weight gain, somnolence, hair loss, thrombocytopenia +++ Anesthetic Choice ++ Inhalational anesthetics are primarily antiepilepticNitrous oxide tends to inhibit seizure spikesBenzodiazepines and propofol are antiepilepticKetamine, etomidate, and methohexital can be proconvulsant with low dosages and should be avoidedHigh doses of fentanyl and alfentanil can trigger epileptiform spike activity on EEGLarge doses of meperidine, atracurium, or cisatracurium should be avoided due to epileptogenic metabolites normeperidine and laudanosineRegional anesthesia is encouraged as long as optimal surgical environment is maintained ++ If seizure occurs ++ Treat with small dose of thiopental 2 mg/kg, midazolam 2–5 mg, or propofol 1–2 mg/kgConsider phenytoin 500–1000 mg IV slow loading dose (or the equivalent as fosphenytoin: less likely to cause hypotension) for prevention of recurrent seizuresIf seizures refractory to above, administer general anesthetic doses of inhalational or IV anesthetics ++ Drug levels of older antiepileptics such as phenytoin need to be monitoredIf patient cannot take po postoperatively, convert to IV and adjust dose ++1. Bhagat H. Anaesthesiologist’s role in management of an epileptic patient. Indian J Anaesth. 2006;50(1):20–22. ++2. Kofke W, Tempelhoff R, Dasheiff R. Anesthetic implications of epilepsy, status epilepticus, andepilepsy surgery. J Neurosurg Anesthesiol. 1997 Oct;9(4):349–372. [PubMed: 9339409] ++3. Kofke W. Anesthetic management of the patient with epilepsy or prior seizures. Curr Opin Anaesthesiol. 2010 Jun;23:391–399. [PubMed: 20421790] ++4. Komotar R. Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurg. 2011 Sep;115(3):483–490. [PubMed: ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.